GlassScriptPhysician profile
Dhiraj Warman
NPI 1184787509
$6,110.93
in general payments reported to CMS, 2019-2025
39 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $499 · 2021: $1,752 · 2022: $1,782 · 2023: $539 · 2024: $570 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,553.51 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,350.02 | 2022-2025 | Bodyguardian, Watchman Flx, Cds - Mct/Cem Monitoring |
| Baylis Medical Company INC | $969.60 | 2021 | |
| Janssen Pharmaceuticals, INC | $549.86 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $416.10 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.15 | 2022-2025 | Lifevest |
| Amgen INC. | $281.01 | 2020-2024 | Repatha |
| Kowa Pharmaceuticals America, INC. | $277.47 | 2019-2022 | |
| Pfizer INC. | $202.16 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $169.84 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $162.13 | 2020-2025 | |
| Lundbeck LLC | $120.66 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $115.29 | 2020-2023 | Farxiga |
| Ultradent Products INC | $112.99 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $99.95 | 2025 | Uptravi, Opsumit |
| Abbott Laboratories | $97.24 | 2019-2024 | Gallant |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $95.83 | 2022-2025 | Wegovy |
| Edwards Lifesciences Corporation | $87.55 | 2023-2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $82.49 | 2019-2025 | Camzyos, Eliquis |
| Bard Peripheral Vascular, INC. | $72.08 | 2021 | |
| Esperion Therapeutics, INC. | $68.18 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.26 | 2021-2025 | |
| Irhythm Technologies, INC. | $52.90 | 2024 | Zio Monitor, Zio Xt Patch |
| Scpharmaceuticals INC. | $44.40 | 2023-2024 | |
| Amarin Pharma, INC. | $36.79 | 2019-2020 | |
| Cardiovascular Systems INC. | $36.24 | 2022 | |
| Nuwellis, INC. | $32.90 | 2021 | |
| Glaxosmithkline, LLC. | $29.91 | 2025 | Arexvy, Shingrix |
| Heartflow, INC. | $23.69 | 2025 | |
| Mozarc Medical US LLC | $22.23 | 2023 | Palindrome |
| Apria Healthcare LLC | $19.44 | 2021 | |
| Philips North America LLC | $18.56 | 2022 | |
| Arbor Pharmaceuticals, INC. | $18.15 | 2021 | |
| Baxter Healthcare | $16.60 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Abiomed | $16.51 | 2025 | |
| Elutia, INC. | $16.41 | 2023 | |
| Dentsply Sirona INC | $14.64 | 2019 | |
| Impulse Dynamics (USA) INC. | $13.89 | 2023 | Optimizer |
| Inari Medical, INC. | $12.78 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Allergan, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhiraj Warman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.